PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability

被引：0
|
作者：
Yu, Jiaojiao [1 ]
Xiang, Yujin [1 ]
Gao, Yuzhen [1 ]
Hua, Fang [1 ]
Zhang, Xiaowei [1 ]
Li, Pingping [1 ]
Cui, Bing [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0437
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [41] Targeting the host immune system: PD-1 and PD-L1 antibodies and breast cancer
    Dawood, Shaheenah
    Rugo, Hope S.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2016, 10 (04) : 336 - 342
  • [42] Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
    Tabana, Yasser
    Okoye, Isobel S.
    Siraki, Arno
    Elahi, Shokrollah
    Barakat, Khaled H.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar Vs
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2016, 96 : 77A - 77A
  • [44] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2016, 29 : 77A - 77A
  • [45] Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
    Wang, Yiting
    Wang, Huanbin
    Yao, Han
    Li, Chushu
    Fang, Jing-Yuan
    Xu, Jie
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [46] IMMUNE EVASION MEDIATED BY PD-L1 ON GLIOBLASTOMA DERIVED EXTRACELLULAR VESICLES
    Ricklefs, F. L.
    Speranza, M. C.
    Hayes, J.
    Balaj, L.
    Breakefield, X. O.
    Bronisz, A.
    Carter, B.
    Freeman, G.
    Lawler, S.
    Chiocca, E. A.
    NEURO-ONCOLOGY, 2017, 19 : 50 - 50
  • [47] IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
    Chan, Li-Chuan
    Li, Chia-Wei
    Xia, Weiya
    Hsu, Jung-Mao
    Lee, Heng-Huan
    Cha, Jong-Ho
    Wang, Hung-Ling
    Yang, Wen-Hao
    Yen, Er-Yen
    Chang, Wei-Chao
    Zha, Zhengyu
    Lim, Seung-Oe
    Lai, Yun-Ju
    Liu, Chunxiao
    Liu, Jielin
    Dong, Qiongzhu
    Yang, Yi
    Sun, Linlin
    Wei, Yongkun
    Nie, Lei
    Hsu, Jennifer L.
    Li, Hui
    Ye, Qinghai
    Hassan, Manal M.
    Amin, Hesham M.
    Kaseb, Ahmed O.
    Lin, Xin
    Wang, Shao-Chun
    Hung, Mien-Chie
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (08): : 3324 - 3338
  • [48] PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay
    Cimadamore, Alessia
    Massari, Francesco
    Santoni, Matteo
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Montironi, Rodolfo
    Moch, Holger
    CURRENT DRUG TARGETS, 2020, 21 (16) : 1664 - 1671
  • [49] Extracellular Vesicles Containing PD-L1 Contribute to Immune Evasion in Glioblastoma
    Lubin, Jonathan A.
    Zhang, Ray R.
    Kuo, John S.
    NEUROSURGERY, 2018, 83 (03) : E98 - E100
  • [50] The emerging roles of PD-L1 subcellular localization in tumor immune evasion
    Liu, Dandan
    Wen, Chengcai
    Chen, Lu
    Ye, Mao
    Liu, Hong
    Sun, Xing
    Liang, Long
    Zhang, Ji
    Chang, Shi
    Liu, Jing
    BIOCHEMICAL PHARMACOLOGY, 2024, 220
12345